Market Cap 55.33B
Revenue (ttm) 21.84B
Net Income (ttm) 1.68B
EPS (ttm) N/A
PE Ratio 13.32
Forward PE 12.96
Profit Margin 7.68%
Debt to Equity Ratio 0.69
Volume 3,347,100
Avg Vol 2,021,006
Day's Range N/A - N/A
Shares Out 286.63M
Stochastic %K 92%
Beta 0.25
Analysts Sell
Price Target $210.46

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-fre...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:13 AM
$BDX is currently trading at $193.04, showing a bullish context as it is near the 60D high of $200.21. The RSI at 59.75 indicates a strong momentum but is not yet overbought, suggesting room for further upside. The price is above both the 30-day MA of 185.95 and the 50-day MA of 186.66, reinforcing a bullish trend. For a trade plan, consider entering at $193.50, slightly above the last close to confirm upward momentum. Set a stop loss at $188.00, which is below the 30-day MA, to manage risk. Target 1 can be set at $198.00, near the 60D high, while Target 2 could be $202.00, allowing for potential breakout gains. This plan leverages current bullish indicators and maintains a risk-managed approach. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:34 PM
$BDX is currently trading at $193.04, showing a strong position relative to its recent performance. The RSI at 59.75 indicates that the stock is nearing overbought territory, suggesting caution but not an immediate sell signal. The price is above both the 30-day moving average (MA30) of 185.95 and the 50-day moving average (MA50) of 186.66, indicating bullish momentum. The recent high of $200.21 and low of $162.29 over the past 60 days suggest a potential range-bound scenario, with resistance near $200. For a trade plan, consider entering a long position at $194.00, with a stop loss at $188.00 to manage risk. Set a first target at $198.00, close to the recent high, and a second target at $201.00, anticipating a breakout above resistance. This strategy leverages current bullish indicators while managing downside risk effectively. https://privateprofiteers.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:05 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · NOV 21, 2025 Exp Entry Price: $1.40 - $1.50 Exit Price Target: $2.20 Profit Margin: +57% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 3:54 PM
$BDX RSI: 61.90, MACD: 0.0198 Vol: 5.56, MA20: 184.24, MA50: 186.63 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:32 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $SATS $LLY $GPC $BDX 2
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:25 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · NOV 21, 2025 Exp Entry Price: $1.70 - $2.10 Exit Price Target: $2.28 Profit Margin: +34% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:08 AM
$BDX is currently trading at $193.04, showing a strong market context with an RSI of 61.27, indicating bullish momentum but nearing overbought levels. The price is above both the 30-day moving average (MA30) of 185.97 and the 50-day moving average (MA50) of 186.64, suggesting a positive trend. The recent 60-day high of 200.21 provides a clear resistance level, while the 60-day low of 162.29 offers support. Directional bias leans bullish given the current price action and RSI positioning. Suggested entry point is around $193.50, slightly above the last close, to confirm upward momentum. Set a stop loss at $188.00 to manage risk. For targets, aim for $198.00 (near the 60D high) and $202.00 as a secondary target. This plan positions for potential gains while maintaining a disciplined risk management approach. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 7:23 PM
$BDX expands its PureWick lineup — what does it mean for investors? 🚀 BD has unveiled a Portable Collection System, enhancing its position in high-growth home-care markets. With shares gaining 34.7% YTD against an industry decline of 10.8%, this move could advance its leadership in urology and chronic care. Explore the full impact on BDX here 👉 https://www.zacks.com/stock/news/2790858/bdx-unveils-portable-purewick-system-for-on-the-go-incontinence-care?cid=sm-stocktwits-2-2790858-body-21000&ADID=SYND_STOCKTWITS_TWEET_2_2790858_BODY_21000
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 6:23 PM
$BDX launches portable PureWick — small device, big potential 💡 The new system targets discreet, on-the-go incontinence care, expanding BD’s reach in the fast-growing home-care market. Discover how this product could strengthen its healthcare footprint 👉 https://www.zacks.com/stock/news/2790858/bdx-unveils-portable-purewick-system-for-on-the-go-incontinence-care?cid=sm-stocktwits-2-2790858-teaser-20987&ADID=SYND_STOCKTWITS_TWEET_2_2790858_TEASER_20987
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:14 AM
$BDX is currently trading at $188.12, showing a neutral RSI of 50.02, indicating no strong momentum in either direction. The 30-day moving average (MA30) at $185.85 and the 50-day moving average (MA50) at $186.54 suggest a slight bullish trend as the price is above both MAs. However, the absence of a 200-day MA limits long-term trend analysis. The recent 60-day high of $200.22 and low of $162.29 indicate a range-bound market. The current price is closer to the high, which may suggest potential resistance around $200. Suggested trade plan: - Entry: $189.00 (above the current price to confirm bullish momentum) - Stop: $185.00 (below the MA30 for risk management) - Target 1: $195.00 (near recent resistance) - Target 2: $200.00 (60D high) Monitor market conditions closely, as volatility (ATR at 4.81) may impact price movements. https://privateprofiteers.com
0 · Reply
Latest News on BDX
BD Board Increases Dividend for 54th Consecutive Year

Nov 6, 2025, 6:25 AM EST - 9 days ago

BD Board Increases Dividend for 54th Consecutive Year


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 14 days ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 17 days ago

Best Dividend Kings: October 2025

ABBV ABM ABT ADM ADP AWR BKH


Becton Dickinson's CFO to depart

Oct 15, 2025, 4:42 PM EDT - 4 weeks ago

Becton Dickinson's CFO to depart


BD Announces CFO Transition Plan

Oct 15, 2025, 4:15 PM EDT - 4 weeks ago

BD Announces CFO Transition Plan


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 6 weeks ago

Best Dividend Aristocrats For October 2025

ABT ADP ATO BEN CAH CHRW CL


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 2 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 2 months ago

Best Dividend Kings: August 2025

ABBV ABM ABT ADM AWR BKH CINF


Becton, Dickinson: Great Time To Buy This Dividend Aristocrat

Aug 18, 2025, 8:00 AM EDT - 3 months ago

Becton, Dickinson: Great Time To Buy This Dividend Aristocrat


BD to Present at Wells Fargo 2025 Healthcare Conference

Aug 14, 2025, 4:15 PM EDT - 3 months ago

BD to Present at Wells Fargo 2025 Healthcare Conference


Becton Dickinson Q3 Beats Estimates On Medical Device Boom

Aug 7, 2025, 11:40 AM EDT - 3 months ago

Becton Dickinson Q3 Beats Estimates On Medical Device Boom


BD Reports Third Quarter Fiscal 2025 Financial Results

Aug 7, 2025, 6:30 AM EDT - 3 months ago

BD Reports Third Quarter Fiscal 2025 Financial Results


Best Dividend Aristocrats For August 2025

Jul 28, 2025, 5:19 AM EDT - 3 months ago

Best Dividend Aristocrats For August 2025

ABT BEN


22 Dividend Kings At Discounted Valuations

Jul 27, 2025, 12:14 PM EDT - 3 months ago

22 Dividend Kings At Discounted Valuations

ABM ADM AMZN AWR BKH CWT FRT


20 Kiplinger July Dividend Favorites: No Cigars

Jul 27, 2025, 11:45 AM EDT - 3 months ago

20 Kiplinger July Dividend Favorites: No Cigars

APD DUK EPD GS HD JNJ KVUE


PrivateProfiteer
PrivateProfiteer Nov. 15 at 8:13 AM
$BDX is currently trading at $193.04, showing a bullish context as it is near the 60D high of $200.21. The RSI at 59.75 indicates a strong momentum but is not yet overbought, suggesting room for further upside. The price is above both the 30-day MA of 185.95 and the 50-day MA of 186.66, reinforcing a bullish trend. For a trade plan, consider entering at $193.50, slightly above the last close to confirm upward momentum. Set a stop loss at $188.00, which is below the 30-day MA, to manage risk. Target 1 can be set at $198.00, near the 60D high, while Target 2 could be $202.00, allowing for potential breakout gains. This plan leverages current bullish indicators and maintains a risk-managed approach. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:34 PM
$BDX is currently trading at $193.04, showing a strong position relative to its recent performance. The RSI at 59.75 indicates that the stock is nearing overbought territory, suggesting caution but not an immediate sell signal. The price is above both the 30-day moving average (MA30) of 185.95 and the 50-day moving average (MA50) of 186.66, indicating bullish momentum. The recent high of $200.21 and low of $162.29 over the past 60 days suggest a potential range-bound scenario, with resistance near $200. For a trade plan, consider entering a long position at $194.00, with a stop loss at $188.00 to manage risk. Set a first target at $198.00, close to the recent high, and a second target at $201.00, anticipating a breakout above resistance. This strategy leverages current bullish indicators while managing downside risk effectively. https://privateprofiteers.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:05 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · NOV 21, 2025 Exp Entry Price: $1.40 - $1.50 Exit Price Target: $2.20 Profit Margin: +57% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 3:54 PM
$BDX RSI: 61.90, MACD: 0.0198 Vol: 5.56, MA20: 184.24, MA50: 186.63 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
_Verticality
_Verticality Nov. 14 at 10:32 AM
Breaking out!? How much volume do you think it takes to gap ARBB up? ARBB has not even 700K shares float and recent news. Hoping for a 100% run on ARBB $SATS $LLY $GPC $BDX 2
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:25 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BDX $190.00 Put · NOV 21, 2025 Exp Entry Price: $1.70 - $2.10 Exit Price Target: $2.28 Profit Margin: +34% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:08 AM
$BDX is currently trading at $193.04, showing a strong market context with an RSI of 61.27, indicating bullish momentum but nearing overbought levels. The price is above both the 30-day moving average (MA30) of 185.97 and the 50-day moving average (MA50) of 186.64, suggesting a positive trend. The recent 60-day high of 200.21 provides a clear resistance level, while the 60-day low of 162.29 offers support. Directional bias leans bullish given the current price action and RSI positioning. Suggested entry point is around $193.50, slightly above the last close, to confirm upward momentum. Set a stop loss at $188.00 to manage risk. For targets, aim for $198.00 (near the 60D high) and $202.00 as a secondary target. This plan positions for potential gains while maintaining a disciplined risk management approach. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 7:23 PM
$BDX expands its PureWick lineup — what does it mean for investors? 🚀 BD has unveiled a Portable Collection System, enhancing its position in high-growth home-care markets. With shares gaining 34.7% YTD against an industry decline of 10.8%, this move could advance its leadership in urology and chronic care. Explore the full impact on BDX here 👉 https://www.zacks.com/stock/news/2790858/bdx-unveils-portable-purewick-system-for-on-the-go-incontinence-care?cid=sm-stocktwits-2-2790858-body-21000&ADID=SYND_STOCKTWITS_TWEET_2_2790858_BODY_21000
0 · Reply
ZacksResearch
ZacksResearch Nov. 13 at 6:23 PM
$BDX launches portable PureWick — small device, big potential 💡 The new system targets discreet, on-the-go incontinence care, expanding BD’s reach in the fast-growing home-care market. Discover how this product could strengthen its healthcare footprint 👉 https://www.zacks.com/stock/news/2790858/bdx-unveils-portable-purewick-system-for-on-the-go-incontinence-care?cid=sm-stocktwits-2-2790858-teaser-20987&ADID=SYND_STOCKTWITS_TWEET_2_2790858_TEASER_20987
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:14 AM
$BDX is currently trading at $188.12, showing a neutral RSI of 50.02, indicating no strong momentum in either direction. The 30-day moving average (MA30) at $185.85 and the 50-day moving average (MA50) at $186.54 suggest a slight bullish trend as the price is above both MAs. However, the absence of a 200-day MA limits long-term trend analysis. The recent 60-day high of $200.22 and low of $162.29 indicate a range-bound market. The current price is closer to the high, which may suggest potential resistance around $200. Suggested trade plan: - Entry: $189.00 (above the current price to confirm bullish momentum) - Stop: $185.00 (below the MA30 for risk management) - Target 1: $195.00 (near recent resistance) - Target 2: $200.00 (60D high) Monitor market conditions closely, as volatility (ATR at 4.81) may impact price movements. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:50 AM
$BDX is currently trading at $188.12, showing a neutral RSI of 50.02, indicating no strong momentum in either direction. The 30-day moving average (MA30) at $185.85 and the 50-day moving average (MA50) at $186.54 suggest a slight bullish trend as the price is above both MAs. However, the absence of a 200-day MA limits long-term trend analysis. The recent 60-day high of $200.22 and low of $162.29 indicate a range-bound market. The current price is closer to the high, which may suggest potential resistance around $200. Suggested trade plan: - Entry: $189.00 (above the current price to confirm bullish momentum) - Stop: $185.00 (below the MA30 for risk management) - Target 1: $195.00 (near recent resistance) - Target 2: $200.00 (60D high) Monitor market conditions closely, as volatility (ATR at 4.81) may impact price movements. https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 4:56 PM
0 · Reply
DavidMacph1
DavidMacph1 Nov. 11 at 2:59 PM
$BDX 20 point move since the ER gap down last week.. Keeping an eye on this; if we get 171 retests, I'll enter.
0 · Reply
Iightning
Iightning Nov. 10 at 9:25 AM
1ightning® Options Trade Alert (Actionable) | Buy $BDX Nov 21 $180 Call | Enter: $10.32 Exit: $19.56 | Profit: 89.47% ROI | https://1ightning.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 9 at 4:06 PM
💎 LiquidTheta® Live Actionable Trade Asset: $BDX Contracts: $BDX December 18, 2026 $180 Calls Scale in: $25.02- $30.58 Scale out: $97.30-$166.80 Profit Potential : 430% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
DividendPower
DividendPower Nov. 8 at 12:58 AM
Recent Dividend Increases - Updated 11/7/25 https://www.dividendpower.org/dividend-increases/ $BDX $CHRW $ATO $ROP $XOM
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:19 PM
RBC Capital has updated their rating for Becton Dickinson ( $BDX ) to Sector Perform with a price target of 202.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 7 at 4:53 PM
$BDX There’s a tremendous amount of value here @ 11x …. Should be $225-$235
0 · Reply
sherowcap
sherowcap Nov. 7 at 1:42 PM
$BDX 10x earnings post the $WAT deal and sentiment remains bearish despite a new huge cost savings plan and at least 2B in buybacks coming in ‘26 plus debt repay from the cash in the deal. Easy buy under 180, FV 240-260 and low risk catalyst only weeks away
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 12:52 PM
Piper Sandler has adjusted their stance on Becton Dickinson ( $BDX ), setting the rating to Neutral with a target price of 200 → 190.
0 · Reply
scientificway
scientificway Nov. 6 at 10:01 PM
$BDX hold it for good profit.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Nov. 6 at 8:10 PM
$BDX there’s massive value here Morningstar has a $270 PT
0 · Reply